Civica
Financial intelligence for Asia's healthcare markets
 
 
Remember me:

Analysis: Medical tourism continues to grow

Bart Van den Mooter, CEO of the TforG Group, looks at the drivers behind the rapid growth in Asia’s medical tourism market.

Asia Pacific is the fastest-growing region in the global medtech market. This growth is fuelled by public healthcare reforms, but even more so by the rapidly expanding private sector and with medical tourism, a connection not often made when the booming medtech market is talked about.

In most Association of Southeast Asian Nations countries, medical tourism represents a third or more of private hospital revenues. With every country looking to extract a piece of this pie, competition between countries and hospitals is intensifying.

In 2016, between 105 and 120 million medical tourists travelled abroad to seek healthcare services. This number is expected to grow by 10-14% annually in the coming three years. Worldwide medical tourism generated €150 billion (US$177 billion) in 2016 and is expected to grow to €200 billion by 2020.

The southeast Asian healthcare market is expanding faster than in other regions, especially driven by the private sector and, notably, medical tourism. Foreign patients are a major revenue generator for private hospitals in the region. Their share represents 40-55% of the private hospitals’ revenue in countries such as Singapore, Malaysia and especially Thailand. In India, medical tourism accounts for 25% of revenue, and in the Philippines, South Korea and Taiwan, it accounts for 10-15% of revenue.

In 2016, the medical tourism sector in Asia Pacific accounted for 10 million patients and €15-17 billion in revenues. For instance, India attracted more than 4 million medical tourists in 2016, generating around €4 billion in healthcare revenues. Similarly, in Thailand, which has perhaps the most advanced medical tourism sector, 3.5 million foreign patients spent more than €4 billion on healthcare in 2016. In Singapore, medical tourism accounted for almost €1.6 billion with close to 900,000 patients in 2016.

The sector will continue to grow 15-17% annually for the coming three years.

Due to fierce competition, private hospitals in the region regularly upgrade facilities and increase capacity. Recently, the sector has started attracting more international hospital groups and investors seeking to enter this lucrative market.

Countries seeking to develop medical tourism are teaming up with large multinational players – for example, Mayo Clinic with Raffles Medical Group in Singapore, Cleveland Clinic Abu Dhabi, John Hopkins Singapore and Anadolo Medical Centre in Turkey. While increasing competition between care providers is leading to differentiating investments and services, it is also leading to increased cost pressure and dilution in quality of healthcare.

The growth of medical tourism in southeast Asia obviously impacts the medtech market. Southeast Asia and India together represent more than €50 billion, or more than 10% of the global medtech market, and are growing faster (7.5%) than any other region in the world.

Market dynamics in the healthcare tourism segment impact the providers of medical equipment and devices in terms of product offerings and customer services. It also creates new opportunities for global as well as local medtech companies. With recent trends, there has been a shift to more day-care and ambulatory procedures in order to deal with staff shortages and cost-effectiveness.

There is also an increased need for telemedicine and e-health to improve the continuum of care. In recent times, medtech companies have increased group purchasing  and central warehousing and are also offering innovative IT-based and value-chain solutions to improve or defend their competitive advantage. They are also shifting from product-focused offerings to customised value-based solutions.

Both push factors and pull factors explain why the medical tourism market has taken off in the region and continues to grow.

Wealthy patients in emerging countries seek high-quality care in high-standard settings, which medical tourism destinations can offer. Middle class and underinsured patients in developed countries feel disenfranchised by their national healthcare systems, which are often plagued by long waiting times for treatments. They shop outside the organised medical system to find services that are affordable, timely or simply available.

Healthcare insurers motivate patients to seek more cost-effective medical provisions outside their home countries, and the usually lower cost of medical treatment in medical tourism destinations is an obvious attraction.

Moreover, national health insurance in developed countries does not typically cover some types of care, such as cosmetic surgery and dental care.

On the other hand, triggered by the opportunities of medical tourism, governments actively promote their countries and hospitals for patients shopping for healthcare services. Healthcare providers deploy referral systems to attract patients, and service companies offer innovative products to guide patients in their choice of country and hospital. To meet this demand, entrepreneurs are building technologically advanced facilities using foreign and domestic capital. They are hiring physicians, technicians and nurses trained to international standards, and where qualified personnel are not available locally, they are recruiting expatriates. Additionally, new service providers in these markets are also offering state-of-the-art healthcare technology for patients.

The increasing affordability of international air fares for intercontinental travel has also played a role in supporting the growth of the regional medical tourism market.

Finally, many nations in the region regard medical tourism as a resource for economic development; for instance, the ministries of tourism in Thailand, Malaysia and India have been aggressively and fiercely promoting medical tourism in their countries. In the same vein, private hospital chains and investors perceive medical tourism in Asia Pacific as an attractive business opportunity and invest in infrastructure, equipment, staff and services.

The market is not without its challenges. Chief among them are political stability. Political stability is a requisite to draw any international tourists, irrespective of whether they are travelling for leisure or medical treatment. For instance, political unrest in Thailand and in some Malaysian provinces had an impact, albeit temporary, on medical tourism in these countries. 

But staff shortages also play a role. The volume of adequately trained clinical staff (doctors and nurses) can hardly keep up with the growing numbers of medical tourists and the level and quality of care they expect. Hospitals hire physicians abroad or collaborate with western hospitals to deal with the shortage. At the same time, they review their operational processes and invest in equipment and solutions that impact the productivity of the hospital.

Significant too is competitiveness and cost pressure. The increasing number of hospitals and investors offering global healthcare services creates in competition between countries, often resulting in price wars that can potentially dilute the quality of healthcare provided.

The medical tourism market in ASEAN is in the midst of a boom, and this is impacting the medtech market, among others. For stakeholders that can mitigate these and other operational challenges, the opportunity is abundant. Much of their success, however, will depend on how governments and the private sector can work together to create a conducive medical tourism ecosystem.

This article first appeared on BRINK Asia

Posted on: 08/11/2017 UTC+08:00


News

Medical diagnostic imaging services provider Capitol Health has said that it expects to return to profitability in the next financial year and has upgraded its outlook for the year.
Paragon Care, a leading distributor and manufacturer supplying medical equipment to hospitals, has said that it is “targeting strong growth in 2018 across all key metrics”.
Malaysian medical glove manufacturer Supermax Group has reported a 42.8% jump in Q1 profits to M$27.9 million (US$6.8 million) on revenues that 16% to M$312 million.
At its annual general meeting, international pathology, imaging and medical centres operator Sonic Healthcare reaffirmed guidance for the year. Chief executive Colin Goldschmidt said that the first quarter of the 2019 financial year confirmed expectations that underlying earnings would grow between 6% and 8% on a constant currency basis.
It has been another great quarter for China Cord Blood Corporation (CCBC), the country’s largest provider of cord blood storage and ancillary services. For the second quarter in a row, profits more than doubled. They came in at US$10.2 million.
New Zealand-based medical device manufacturer Fisher & Paykel Healthcare has reported a steady set of first half figures. Profits were up 4% to NZ$81.3 million (US$55.3 million) on revenues that rose 8% to NZ$458.4 million.
Retirement village operator Arvida has reported a 14.5% slump in profits for the first half of the year to NZ$14.5 million (US$9.9 million). At the same time, revenues were up 27.9% to NZ$60 million.
Medical device manufacturer Microport Scientific Corporation plans to acquire the cardiac rhythm management (CRM) business of London-based medical device manufacturer LivaNova for US$190 million.



Analysis

The promise of a bottom in Singapore’s office market has caused its ranking as an investment market to soar from next-to-bottom last year to third in this year’s “Emerging Trends in Real Estate Asia Pacific 2018” report, a real estate forecast jointly published by the Urban Land Institute (ULI) and PwC.
Kamal Brar, vice president and general manager of Asia Pacific for data software company Hortonworks, looks at how data analytics can provide effective and affordable healthcare in Singapore.
The latest Sun Life Financial Asia Diabetes Awareness Study reveals an alarming knowledge gap in diabetes. A third of Asian women who are or were pregnant in the past three years are unaware of the risk of developing gestational diabetes in pregnancy, while one in seven births in Asia is currently affected by gestational diabetes.
Gan Kim Yong, Singapore’s minister for health, explains why the private sector needs to get behind the National Electronic Health Record System.
Business leaders in Asia Pacific’s healthcare industry are showing urgency in embracing the fourth industrial revolution, according to the Microsoft Asia Digital Transformation Survey. More than three-quarters of them believe that they need to transform to a digital business to enable future growth and yet only a quarter said that they have a full digital strategy in place today.
An agreement for an additional US$15 million funding from the World Bank will be used to expand health and nutrition coverage in the Lao People's Democratic Republic. It is expected to benefit more than 1 million people across 14 provinces.
Bart Van den Mooter, CEO of the TforG Group, looks at the drivers behind the rapid growth in Asia’s medical tourism market.
The ambitious healthcare agenda under Moon Jae-in's liberal presidency will seek to expand national health insurance reimbursement and limit the burden of excessive medical costs, while overhauling the healthcare system. BMI Research looks at the winners and the losers in the presidential agenda.


Civica

Podcasts

AON

Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices